A design change involving replacement parts for a commonly used CPAP mask has triggered a Class I recall for Compass Health.
Antares Pharma has agreed to help Pfizer develop a combination drug-device rescue pen using Antares' QuickShot device.
FDA gave ReCor Medical the green light to run a pivotal study of its ultrasound-based renal denervation system for the treatment of hypertension.
Two recent studies have found a significant decrease in the occurrence of infections when Silverlon antimicrobial wound dressings are used.
We want to raise the profile of the young people doing groundbreaking work in the medical device and diagnostic industry. Do you know any industry innovators under the age of 30? Tell us who should make the 2018 list! Email nominations to [email protected] with the subject line: Medtech's...
An expert from Boston Scientific shares insights to help you understand your users and answers questions from industry peers on design validation.
A University of California, San Francisco program provides the infrastructure for surgeons to innovate.
FDA is calling on innovators to develop medical devices, digital health technologies, and diagnostic tests capable of addressing the opioid epidemic.
A recent study highlights the benefits of using powered staplers, rather than manual staplers, during lung-removal surgery.
Google's sister company, Verily, is reportedly working on a wearable that could potentially collect blood using a system of exploding microneedles and magnets. The project has not been publicly announced yet and is still years away from commercialization.
The recent box office hit Avengers: Infinity War inspired us to explore the main villain's motivation for wiping out half the universe. Could medical technology solve these global problems in a more ethical way?
InVivo Therapeutics presented complete six-month results from its INSPIRE study, which was temporarily halted after three patients died during the study last year.
Industry professional says that overlooking user research in product design could lead to some missed opportunities and dire consequences.
Is it possible for established medical device companies to drastically reduce their time to market by cutting back on QMS documentation, while still meeting FDA requirements?